Article · 20 May 2025
Review articlePublished 26 Jul 2016
Chemotherapy in brain metastases of lung and breast cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Brain metastases are the most common intracranial tumors and their incidence is increasing. Results of a recent analysis have confirmed that good performance status, control of the primary tumor, absence of extracranial disease and age less than 65 years are predictive of survival. Without treatment, patients with brain metastases survive approximately 1 month after diagnosis. Currently, chemotherapy has a limited role in the treatment of most brain metastases. Several regimens and new therapies, with a good penetration through the blood–brain barrier, such as Temozolomide (Temodar®, Shering Plough Corp.), have been used in brain metastases with different results depending on the histology of the primary tumor and on the administration schedule. A better understanding of the complex processes underlying the development of brain metastasis will enable us to develop more satisfactory targeted treatments.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Practice.
Article · 20 May 2025
Histological effects of doxorubicin and baobab plants on some organs of rat
Article · 28 Mar 2025
Using
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Practice
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Alicia Tosoni”
- BylineArticles whose byline prints “Sara Lonardi”
- BylineArticles whose byline prints “Linda Nicolardi”
- BylineArticles whose byline prints “Alba A Brandes”